Researchers examined data on 5,360 adult patients and found that of the 1,437 diagnosed with prediabetes, none were referred to the CDC's National Diabetes Prevention Program and those who had point-of-care A1C testing were 4.7 times more likely to receive a metformin prescription than those who had laboratory testing. The findings in the Journal of the American Board of Family Medicine also revealed that 97% of clinicians believed prediabetes to be an important health issue and 65% believed prediabetes screening is important.
Prediabetes patients don't get referred to CDC's prevention program
Sign up for DiabetesPro SmartBrief
News for diabetes health professionals
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.